###### Strengths and limitations of this study

-   First Swiss prospective and systematic collection of incident data in primary care.

-   Covering three linguistic regions and two distribution systems.

-   Bias from selective and under-reporting or non-detection.

Introduction {#s1}
============

Patient safety is a major concern in healthcare systems worldwide. Although most safety research has been conducted in the inpatient setting,[@R1] evidence indicates that medical errors and adverse events pose a serious threat for patients in the primary care setting as well, since most patients receive ambulatory care.[@R2] Gandhi and Lee[@R5] noted that safety concerns in the outpatient setting differ from those in the hospital setting in obvious and non-obvious ways. Medication-related incidents are also important in primary care, but are perhaps not as well documented as in secondary care. A study by Gandhi and Lee[@R6] in primary care showed that 25% of 661 ambulatory care patients with at least one prescription had such an incident, of which 13% were classified as serious and 39% as preventable or ameliorable. In a study by Pirmohamed *et al* in the UK, medication-related incidents caused about 6.8% of all hospitalisations[@R7] and in Switzerland, these incidents are responsible for about 7.2% of hospitalisations.[@R8] Diagnostic errors[@R9] and adverse drug events have been identified as frequent safety concerns; furthermore, there is a body of literature about the safety of outpatient procedures and the consequences of coordination as well as continuity-of-care failures.[@R10] Hospital and outpatient care also differ in their infrastructure and in many processes, as well as in their ability to detect, monitor and address safety issues. Information about the frequency and outcomes of safety incidents in primary care is required to identify risks or 'hot spots', to prioritise them and to take action as needed.

Definition of terms {#s1a}
-------------------

For the purpose of our study, we use the terminology of the International Classification for Patient Safety (WHO).[@R11] Here, a *patient safety incident* is defined as an event or a circumstance which could have resulted or did result in unnecessary harm to a patient. There are several possible causes. (1) An *error*, defined as: failure to carry out a planned action as intended or an application of an incorrect rule; (2) A *violation*, defined as: deliberate deviation from an operating procedure, standard or rule; (3) An (external) *circumstance*, defined as: a situation or factor that may influence an event, agent or person. We want to distinguish incidents from *adverse drug reactions* (ADR) which are defined as: unexpected harm resulting from a justified action where the correct medication process was followed for the context in which the event occurred. The same applies to *drug--drug* or *drug--disease interactions* (DDI). *Critical Incident Reporting System* (CIRS) refers to a voluntary anonymous database system to which Swiss family physicians or paediatricians may report incidents as those occurred in their practices.

We will restrict the topic of our study to medication-related incidents. *Medication* or medicine refers to a pharmaceutical drug, officially called a medicinal product, which can be loosely defined as any chemical substance---or product comprising such---intended for use in the medical diagnosis, cure, symptomatic treatment, or prevention of disease (Wikipedia).

Information retrieval {#s1b}
---------------------

Methods to collect information about adverse incidents are manifold.[@R2] [@R11] In the literature, different ways to collect adverse incident information are described: voluntary versus mandatory reporting systems, patient questionnaires, or pharmacists reporting to registries. Interviews can be held with physicians or questionnaires can be filled out by them. Charts of deceased patients can be audited meticulously or medicolegal cases may be analysed. Information may be derived prospectively in an actual case by case manner or retrospectively along case vignettes. The two methods most commonly used are incident reporting and chart review. Both methods have the potential to systematically cover information on the entire range of safety events in medical offices in common.

*Incident reporting* has a long tradition in clinical risk management and is increasingly used in outpatient care.[@R15] Indeed, incident reporting has been the dominant method for the study of safety incidents in primary care.[@R19] It is based on voluntary and usually anonymous reports of physicians and nurses, and is used to describe the types and characteristics of patient safety incidents. These reports may vary considerably with respect to the information which is included and the likelihood of 'true' incidents being reported is unclear. Studies based on this method describe large variations in the number of reports submitted.[@R20] Moreover, professional groups differ in their frequency of reporting; in-hospital care physicians reported preferentially severe incidents, while nurses cover the whole spectrum of impact levels.[@R20] Selective reporting by physicians may have multifactorial causes such as lack of time, thinking that an ADR which is already known is not worth mentioning, or concerns about data confidentiality. Non-reporting may be as frequent as 94%.[@R21] [@R22] O\'Beirne *et al* concluded from a very low report rate (\<1 report per person per year) that incident reporting may be "a costly but not very effective way to study safety problems in primary care".[@R23] A recent Swiss study analysed safety issues in primary care.[@R12] This was a semiquantitative, retrospective investigation involving over 300 nurses and physicians. Seven of 23 issues were related to drug treatment. Frequently named issues were insufficient monitoring of potential side effects, missing prescriptions of required treatment, and errant medication relating to the route of administration, dosage or timing. The low and perhaps, selective reporting of incidents in any system makes it difficult or virtually impossible to collect valuable quantitative information from CIRS.[@R24]

In *chart review*, medical records are analysed by independent experts in order to identify adverse events, and to assess potential harm and preventability in each case.[@R25] Such analysis requires complete and correct patient documentation to provide valid results. In many cases relevant information may be unavailable.[@R25] As chart review is a time-consuming approach, many resources are needed to analyse a large number of patient records at different primary care offices; furthermore, this kind of analysis is usually retrospective.

Sandars and Esmail[@R2] described a frequency of 5--80 medical errors per 100 000 consultations in primary care patients. Incidents, as defined above, may also result from circumstantial factors (without any errors) and therefore, occur somewhat more frequently. In order to not overburden the participating physicians with our study, we decided to limit our focus to medication incidents. These make up between 9% and 42% of all registered incidents[@R2] [@R9] [@R26] and of these, approximately 70% may be prescription errors.[@R29] In contrast to the study by Sandars and Esmail, our pilot study found a rate of approximately one medication incident per 2 months and per physician (see online supplementary appendix 1), while the former reported a rate of about one in 2 years.

Concerning predisposing factors, Avery *et al*[@R30] found a propensity for becoming a victim of medication errors with the young (\<15 years) or elderly (\>64 years) ages. The latter was confirmed by Salanitro *et al.*[@R31] Two studies by Field *et al*[@R32] [@R33] reported morbidity as promoting errors. All studies listed polymedication as a key factor.[@R30] Better knowledge of factors associated with medication errors would be helpful to implement preventive measures and therefore, reduce the frequency of avoidable incidents in the future.

The Swiss National Sentinel Reporting Network (http://www.sentinella.ch) {#s1c}
------------------------------------------------------------------------

To apply a supplementary method to gaining insight into safety hot spots in primary care, we aim to assess medication errors by using the Swiss National *Sentinel Reporting Network*. Founded in 1986, it was mainly designed to survey transmissible diseases. Later, it also assessed other health problems of public interest. In 2015, besides our project, the areas covered are: surveillance of mumps, whooping cough, flu or *Borrelia,* pneumonia and middle ear infections, tick bites, vaccinations against measles or whooping cough, and alcohol use among adolescents. One hundred and forty general internal medicines and 27 paediatric practices report to the system, 109 of them in the German, 44 in the French, and 14 in the Italian part of Switzerland. It generates daily to weekly current data and covers the entire geographic and linguistic regions of our country.

Method {#s2}
======

Aims of the project {#s2a}
-------------------

To describe the type, frequency, seasonal and regional distribution of medication incidents in primary care in Switzerland and to elucidate possible risk factors such as age, gender, polymedication, morbidity, and previous hospitalisation.

Study design {#s2b}
------------

We will conduct a prospective surveillance study to identify cases of medication incidents among primary care patients over the course of 1 year.

Population {#s2c}
----------

Any person undergoing drug treatment in general internal or paediatric practices participating in the Sentinella network. The latter covers a representative sample of patients in primary care for Switzerland (see above). These patients include children, individuals with mental retardation or the elderly---all of whom might be at increased risk for medication errors.

Inclusion criteria {#s2d}
------------------

-   Any *erroneous* event (as defined by the physician) relating to the medication process and interfering with the normal treatment course.

Exclusion criteria {#s2e}
------------------

-   Lacking treatment effect, ADR, or drug--drug interaction or DDI *without* detectable treatment error.

-   Refusal of patients to refer data to the Sentinel system.

Questionnaire development {#s2f}
-------------------------

As we could not identify questionnaires suitable for continuous reporting and adaptable to our local conditions, we had to develop new ones. We tested these in an 8-week pilot study (see online supplementary appendix 1).

In the Sentinella study, the Italian speaking physicians had to decide whether to report in German or French. For the main study, we developed only two language sets of questionnaires, since these had to be filled in only by physicians, not by patients. We deemed assessment of construct validity of the questionnaires not imperative, since we did not measure hidden constructs (like 'depression') by our questions and information was mainly needed about influencing our target variable, that is, the type and frequency of incidents.

Data to be collected {#s2g}
--------------------

The data to be collected in our study are summarised in [boxes 1](#bx1){ref-type="boxed-text"} (physician related) and [2](#bx2){ref-type="boxed-text"} (patient related/incident related); for the latter, only pre-existing data from medical records will be collected. Furthermore, we collected denominator data as depicted in [box 3](#bx3){ref-type="boxed-text"}. Box 1Physician-related dataInitial questionnaireSentinella identification numberGender\*Age\*Specialisation (general practitioner or paediatrician)\*Number of physicians in practice, and among them those reporting to Sentinella\*Working hours per week\*Drug distribution system (by pharmacist or by physician)Drug prescription system (electronic, machine written, hand-written)Electronic drug--drug interaction (DDI) systemAvailability of X-ray, ECG, ultrasoundMedical history (electronic or paper based)Quality certificateTeam sessionsPhysician\'s participation in quality circleLocalisation (urbanity, language region)\*Special education/interestsCaring for institutionsFinal questionnaireProportion of non-reporting incidents during the studyThe data are collected from each physician reporting to the Sentinella system. The questionnaire and the coding plan are available at <http://www.medication-incidents.ch>.\*These data is delivered by Sentinella administration. All other data will be collected by use of questionnaires. Box 2Patient-related dataPatient-related/incident-related itemsWeek of reportingYear of birthGenderPhysician-to-patient relationshipDwelling situationSocial problemsDementia or learning disabilitiesPsychiatric problemsUse of psychotropic drugsLinguistic problemsSmoking or substance abuseVisual blurring or hearing lossGait disturbanceRenal insufficiencyLiver cirrhosis/insufficiencyPrevious hospitalisation (12 months)Care dependencyNumber of chronically administered active drugs\*Number of diagnoses for chronic diseaseScale value of 'Thurgau Morbidity Index' (TMI)[@R35]Description of incidentWho noticed the incidentWhat went wrongName of drugOther drugs used possibly related to the incidentEndangering of patientAmount of damageOrgan system involvedDurationRecoveryTreatment/surveillanceCausal triggersInterface problemsInformation to the patient about the incident and his reactionConsequences of the incidentResponsibilityPossibility to anticipate the incidentWhether a similar incident was previously notified within the studyGeneral proposalsPhysician-related itemsSentinella identification numberThe data are collected for each incident. The *basic reporting* of a medication incident is collected weekly. It includes the Sentinella identification number, the gender of the patients and their year of birth. The questionnaire and the coding plan are available at <http://www.medication-incidents.ch>.\*Each regularly prescribed or administered pharmacological specialty counts per active substance contained, according to the latest available medication list. All therapies regularly taken during at least 1 month are considered. Drugs that are prescribed for shorter periods (eg, antibiotics for a week) are not included. Regularly administered eye drops, inhalations, nasal sprays count if a general systemic effect is intentional (eg, calcitonin nasal spray) or must be taken into account (eg, timolol eye drops). Also transcutaneous, subcutaneous or vaginal hormone-releasing systems, and preparations administered by the specialist (eg, gynecologist: birth control pills) should be recorded. Herbal drugs count---regardless of the number of plants---as one medication. Homeopathic drugs, cell salts, etc, are not counted. Multivitamins count if they are taken due to a medical indication (eg, short bowel syndrome), but not when the administration was adopted as 'roborant'; multivitamins are considered *one* drug. Also therapies at the hospital administered such as oncology are counted. Whether the patient also applies the drug (compliance) is irrelevant to the study, the important thing is that it is so prescribed. Prescribed medications to relieve on requirement which do not need to be taken daily, or self-medication is not recorded. Box 3Denominator dataFortnight analysis (only once in study, from 7 to 20 March 2015)Previous hospitalisation (during the preceding year)Care dependencyNumber of active drugs chronically administeredNumber of chronic diagnosesScale value of 'Thurgau Morbidity Index' (TMI)[@R35]Year of birth\*Gender\*Multiple consultation (within the 14-day period)Sentinella identification numberDaily analysisPhysician-to-patient contactsSentinella identification numberThe data are collected from each patient consulting the practice during the year 2015, irrespective of the presence of an incident.\*Year of birth and gender will be collected during another 14-day period in fall but without the other items. The questionnaire and the coding plan are available at <http://www.medication-incidents.ch>. Definition of medication count: see [box 2](#bx2){ref-type="boxed-text"}.

Time schedule {#s2h}
-------------

The pilot study took place from July until September 2013. The final questionnaires in both languages and their English translation are available at <http://www.medication-incidents.ch>. The main study takes place from January until December 2015. Evaluation of the study data and writing of the publication will be performed in 2016.

Statistics {#s2i}
----------

### Expected number of cases {#s2i1}

On the basis of our pilot trial (see online supplementary appendix), we expect at least one drug-related incident to be reported every 2 months per physician. In the Sentinella system, there are currently 167 physicians actively reporting, among them are 27 paediatricians. When assuming that they work 10 months per year, this would result in 660 reported incidents. We, hence, have to decrease this number to some extent because not all physicians work 100%, there will be some non-reporting or non-detection of incidents, and paediatricians report lower rate of incidents (according to the results of our pilot study). So we expect approximately 500 incidents in our study.

Statistical methods {#s2j}
-------------------

For the analysis of our data, we will use descriptive statistics in order to describe the type, frequency, seasonal and regional distribution of medication incidents. We will use logistic regression to assess the association of medication incidents with potential risk factors. We will use SPSS.

Independent ethical committee {#s2k}
-----------------------------

The ethical committee of Canton Zurich decided that our study did not need formal approval, because the data are completely anonymous (KEK-ZH 2014-0400). The study was recorded in <http://www.ClinicalTrials.gov>: NCT02295371, as well as in our national study registry (<http://www.kofam.ch>; SNCTP000001207).

STROBE statement: Where applicable, our publication will follow the general STROBE guidelines (<http://www.equator-network.org/>).

Results from a pilot study {#s3}
==========================

From the existing literature,[@R12] we included questions on the social and clinical state of the patients, on the type of incident, and on possible causative factors, and tested these in a pilot study, from July until September 2013, with a sample of general physicians or paediatricians; these were in two language sets (German and French) for the three different language regions of Switzerland (German 11, French 7, Italian 3) for 8 weeks. Fifty-one cases were recorded, leading to an incident rate of 0.4 (median, IQR 0.4) per family physician, and week or 4 (5) per family physician and 1000 patient contacts. Virtually no incidents were observed by paediatricians (details of this study are presented in online supplementary appendix 1).

Discussion {#s4}
==========

Strength and limitations {#s4a}
------------------------

Our study is the first prospective and systematic collection of incident data in Swiss primary care. The well-motivated reporting physicians, the duration of 12 months and the coverage of the three main linguistic regions as well as of two drug distribution systems will deliver new and relevant insights.

Not all cases may be reported; there may be some selective reporting of cases of higher clinical importance, and some cases may not be reported due to lack of time or legal considerations. Some cases may not be detected by the physicians. Some non-prescription treatments may be missed if they are not causally linked to the incident. The sample size may be too small for inferential statistics. The 14-day denominator period may not be representative for the patient collective over the whole year. The definition of inclusion criteria may be interpreted varyingly by the physicians. Qualitative information may be missed in this study and has perhaps to be further addressed in qualitative research. The low and perhaps selective reporting of incidents in any system makes it difficult or virtually impossible to collect valuable quantitative information from CIRS.[@R24]

Conclusion {#s5}
==========

Data on safety issues in ambulatory primary care patients is scarce and this is also true for Switzerland. The retrospective qualitative study by Gehring *et al*[@R12] and the study by Livio *et al*[@R8] on hospitalisations makes it reasonably clear that things are in no way better than that in UK[@R7] or USA,[@R6] where 6.5% of all hospitalisations and 4.0% of all hospital care days as well as 1 in 667 hospital deaths are caused by medication incidents. Since up to 72% of these appear to be preventable or ameliorable, it seems worthwhile to focus on these so as to further elucidate risk factors.

The data of our study should allow for describing the type, frequency, seasonal and regional distribution of medication incidents in Swiss primary care practices and for helping to identify risk factors. The definition of 'hot spots' could sensitise the physicians to focus on dangerous situations and help them to redefine their standing operational procedures (SOPs).
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